Plain-English translation of NCT05661786 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study that follows people with hepatitis B who fall into an 'indeterminate phase'—meaning their blood test results don't fit neatly into the typical disease categories. Researchers want to understand what happens to these patients over time, including whether they develop complications like liver scarring or cancer. No medication is being tested; instead, participants will be monitored regularly to see how their liver disease progresses.
Many people with hepatitis B have blood test results that don't match the standard disease phases doctors usually recognize. Right now, doctors don't have clear guidance on how to treat or monitor these patients, so this study aims to fill that gap by tracking what actually happens to them over time.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic at regular intervals for blood tests, physical exams, and possibly liver ultrasound or stiffness measurements to track how your liver is doing. The study will follow you for several years to see how your disease changes over time. You would not receive any new medication as part of this study—it is purely observational to help doctors better understand your condition.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
China